GPP
PASG icon

Great Point Partners’s Passage Bio PASG Stock Holding History

Great Point Partners’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,695
Closed -$353K – 40
2022
Q1 		$353K Sell
5,695
-70,210
-92% -$5.79M 0.09% 29
2021
Q4 		$9.64M Buy
+75,905
New +$12.4M 2.14% 22

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Great Point Partners's PASG Position: Q2 2022 in Review

Great Point Partners sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 5,695 shares — an estimated $353K sold.

Great Point Partners first reported a position in PASG in Q4 2021 and held it in 2 quarters. The position peaked at $9.64M in Q4 2021. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • Great Point Partners reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • Great Point Partners sold 5,695 Passage Bio shares in Q2 2022, an estimated $353K.
  • Great Point Partners first reported a position in Passage Bio in Q4 2021 and held it in 2 quarters.
  • Great Point Partners's Passage Bio position peaked at $9.64M in Q4 2021.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Great Point Partners's 13F filing for Q2 2022, filed 15 Aug 2022.